Singapore: The steady decline in new ebola cases presents a formidable challenge to current and future clinical trials o...
Singapore: Bristol-Myers-Squibb Foundation has released nine new grants totaling to around $3.5 million towards hepatiti...
Singapore: AMRI has completed the acquisition of Cedarburg Pharmaceuticals, a contract developer and manufacturer of tec...
Singapore: Researchers from Shanghai Institute of Materia Medica, Chinese Academy of Science, have discovered that Latan...
Singapore: Australia-based QRxPharma has resubmitted its Moxduo new drug application (NDA) after the US Food and Drug Ad...
Singapore: Eli Lilly has partnered with German firm, BioNTech, to discover novel cancer immunotherapies through body's o...
Singapore: Boehringer Ingelheim has established a translational research collaboration with the presidents and fellows o...
Singapore: Indian pharma company Cadila Healthcare that operates under the aegis of Zydus Group, has launched its patent...
Singapore: Astellas Pharma has obtained the marketing approval of Irribow OD 1 Tablets 2.5µg / 5µg (generic name: ramo...
Singapore: Biotron, a clinical-stage drug development company focused on development of new generation antiviral drugs, ...
After geting the regulatory approval in early 2013, Biocon, India's number two biotech company by revenues, released the...
Singapore: Bioventus, which specializes in active orthopaedic healing, has acquired exclusive, worldwide license to Pfiz...
Singapore: Merck, known as Merck Sharp & Dohme (MSD) outside the US and Canada, provided update on its clinical prog...
Singapore: Hong Kong Trade Development Council (HKTDC) and Modernized Chinese Medicine International Association (MCMIA ...
Singapore: Australia-based biotech company, Viralytics, achieved the primary endpoint in its phase II clinical trial of ...
Singapore: Oramed Pharmaceuticals, developer of oral drug delivery systems, submitted a pre-investigational new drug (pr...
Singapore: GE Healthcare Life Sciences has licensed Cellular Dynamics International, US-based commercial producer of hum...
Singapore: Global phase III clinical trial of once-daily edoxaban for the treatment of acute symptomatic deep vein throm...
Singapore: Johnson & Johnson (J&J) discontinued phase III clinical development of bapineuzumab intravenous (IV) ...
Singapore: German firm Evotec has acquired Sanofi's drug discovery operation in Toulouse to build an European centre of ...
Roche has announced that the US Food and Drug Administration (US FDA) has granted Breakthrough Therapy Designation for t...
May 3, 2016: Australia-based Prima BioMed Ltd has announced that the company has been granted patent number 5908210 enti...
Japanese pharma giant Astellas Pharma Inc. and The University of Texas MD Anderson Cancer Center has signed an option ag...
Singapore: Merck Millipore, the Life Science division of Merck, has appointed Dr Udit Batra as its new President and CEO...
Singapore: US Pharmacopeial Convention (USP), a nonprofit global health organization that creates and promotes quality s...
Singapore: Adagene, China based antibody discovery and development company, has raised USD28 million Series B financing ...
‎Singapore: Merck Serono, the biopharmaceutical division of Merck, has signed a global licensing, co-development, ...
Singapore: Pneumonia remains the single biggest killer of children under the age of five globally, claiming the lives of...
Singapore: Australia-based Patrys, a clinical stage biotechnology company, has been granted orphan drug designation by t...
Singapore: US-Australian drug discovery company, Novogen's drug candidate, Anisina, has progressed successfully in pre-c...
Over the past decade the world's centre of economic gravity has shifted from US and Europe to Asia at a speed and scale ...
Singapore: A research team led by scientists from National University of Singapore (NUS) has identified several potent i...
Singapore: China biotech firm, Innovent Biologics, has raised $100 million in Series C financing led by Legend Capital, ...
Singapore: Scientific consensus in the Network Verification Challenge, conducted in Spain from 15-18 June 2015, has exhi...
Dr Alex Matter, CEO, Experimental Therapeutics Center, A*Star, Singapore, is among the pioneers of the world's first tar...
Singapore: Cancer Council NSW, Australia's non-government cancer research funder, has granted almost $7 million to resea...
Singapore: US-Australian drug discovery company, Novogen, in conjunction with Australian paediatric cancer researchers, ...
Singapore: The World Health Organization (WHO) is urging governments to act against the five hepatitis viruses that can...
Singapore: Australian drug discovery company, Novogen, has developed anti-tropomyosin drug candidate, Anisina, which has...
Singapore: Australia-based Starpharma Holdings has achieved improved tumor-inhibiting efficacy and reduced overall toxic...
Singapore: Australian drug delivery technology company, Phosphagenics, will be returning to the clinic with its oxycodo...
The drug delivery technology landscape is rapidly evolving with new classes of pharmaceuticals and biologics fuelling th...
Singapore: Australia based pharmacuetical company, Starpharma, has appointed Mr Robert Thomas to the Board as a non-exec...
Singapore: Australia's Balnaves Foundation has donated $450,000 to the University of Sydney's medical school to help pro...
Singapore: Australian biopharmaceutical company, Specialised Therapeutics Australia (STA), and Helsinn, a Swiss group fo...
Singapore: Two approved drugs, an antifungal and a steroid, may potentially take on new roles as treatments for multiple...
Singapore: A group of researchers from Institute of Bioengineering and Nanotechnology (IBN) is using green tea ingredien...
Singapore: Singapore and Scotland based TauRx Pharmaceuticals, a clinical-stage biopharmaceutical company developing a n...
Singapore: Phase II clinical trials by scientists from the National Institute of Allergy and Infectious Diseases (NIAID)...
Singapore: Daiichi Sankyo is going to establish a new company named Orphan Disease Treatment Institute, along with Innov...
Singapore: Sinovac Biotech, a leading China-based vaccine manufacturer, has been selected by the Jiangsu Centers for Dis...
Sydney-headquartered Regeneus announced the completion of enrolment of all 20 patients in the STEP trial. Further, a rev...
Singapore: Pfizer's high hopes for its JAK3 (Janus kinase) inhibitor, tofacitinib (tasocitinib, CP-690550), now branded ...
Singapore: Ampio Pharmaceuticals has taken its candidate NCE001 from its proprietary methylphenidate derivatives family ...
Singapore: The US FDA Cardiovascular and Renal Drugs Advisory Committee has disapproved Japan-based Otsuka Pharmaceutic...
Singapore: Global pharmaceutical company, Pfizer, and Japanese firm, Kyowa Hakko Kirin, are jointly assessing the therap...
Singapore: The Network Verification Challenge has generated a comprehensive set of biological models relevant to chroni...
Singapore: Australia-based Prana Biotechnology has achieved positive result in its phase II clinical trial investigating...
Singapore: Novartis has partnered with Global Alliance for TB Drug Development (TB Alliance) for compounds to fight tube...
Singapore: China's ShangPharma appointed Dr Art Taveras as president and chief scientific officer (CSO). He will be resp...
Singapore: Professor John Wong Eu-Li, currently chief executive of National University Health System (NUHS), Isabel Chan...
Singapore: Taiwan based TWi Pharmaceuticals has received US FDA and Taiwan FDA approval of a protocol for a Phase II cli...
Singapore: Japan's Ono Pharmaceutical and Kyowa Hakko Kirin has partnered with Bristol-Myers Squibbs for Phase 1 clinica...
Singapore: Novartis has acquired the license for exclusive right to use Antibody-Drug Conjugate (ADC) technology from ...
Singapore: BioBusiness Asia concluded in Taiwan on July 18, 2013, with a message that the global biotech fraternity need...
Singapore: National Health Innovation Centre (NHIC) of Singapore has partnered with global pharmaceutical company, Astra...
Singapore: Japan's Chugai Pharmaceutical filed an application with the Japanese Ministry of Health, Labour and Welfare, ...
Singapore: Singapore's Agency for Science, Technology and Research (A*STAR) and Japan's Sumitomo Mitsui Banking Corporat...
Singapore: The Mainland Affairs Council (MAC) recently announced that Taiwan and China have reached a concrete consensus...
Singapore: European Commission has approved Eliquis (apixaban) for prevention of stroke and systemic embolism in adult p...
Singapore: Eli Lilly and Company completed its phase III study regarding stage IV metastatic squamous non-small cell lun...
Singapore: South Korea's Dong-A Pharmaceutical announced positive top-line results from its phase II clinical trial of D...
Singapore: US-based Ariad Pharmaceuticals has granted Specialised Therapeutics Australia (STA), a specialty pharmaceutic...
Singapore: Japan-based Eisai and Santen Pharmaceutical entered into an option agreement which grants Santen rights of ev...
Singapore: Takeda Development Center Shanghai (TDC Shanghai) and Takeda Development Center Asia has commenced TOURMALINE...
Singapore: China's Food and Drug Administration plans to remove its mandatory animal test requirements for domestically ...
Singapore: Japan-based global analytics technology provider, Shimadzu (Asia Pacific), has launched i-Series of new indus...
Singapore: China's HUYA Bioscience has struck a partnership with Changzhou Center for Biotech Development (CZCBD) to foc...
Singapore: Australia based drug development company, CSL, has secured the necessary approvals required to proceed with t...
Singapore: Australia-based Bionomics has initiated a Phase 1b clinical trial in healthy volunteers of BNC210, the drug c...
Singapore: The US Food and Drug Administration has formed an internal task force that will support the development of ne...
Singapore: In a bid to boost drug pipeline, Gilead Sciences has acquired Farnesoid X Receptor (FXR) program comprising s...
Singapore: Global bio pharmaceutical company, Merck Sharp and Dohme, has received USFDA nod to review the supplemental b...
Singapore: A Chinese biotech firm, Chipscreen Biosciencees has received the China FDA nod for its flagship drug Epidaza ...
Singapore: Australian drug development company, Invion, has completed the enrolment in its phase II clinical trial of IN...
Singapore: Nature Biotechnology has published a peer-reviewed paper co-authored by the Biotechnology Industry Organizati...
Singapore: Clinical research company, CPR Pharma Services, launched a new laboratory, in Adelaide, Australia, to provide...
Singapore: The US Food and Drug Administration (FDA) has approved Genentech's Perjeta for people with her2-positive met...
Singapore: Monash Institute of Pharmaceutical Sciences (MIPS) has been recognised for the Monash-GSK Australian Centre f...
Singapore: National Institutes of Health (NIH) Clinical Center has suspended operations of its Pharmaceutical Developmen...
Singapore: Researchers at the National Institutes of Health (NIH) have identified a potential new drug that could help i...
Singapore: Alexion pharma has announced the submission of New Drug Application (NDA) to the Japanese Ministry of Health,...
Singapore: Japanese pharma major Takeda Pharmaceutical Company has announced that the randomized, double-blind, placebo-...
Singapore: A phase II interim analysis of a randomized study involving Boehringer Ingelheim's investigational haematolog...
Singapore: Australian biotechnology company Minomic International has collaborated with US partner to develop a potentia...
Singapore: The US Food and Drug Administration (FDA) has granted Genmab and GlaxoSmithKline (GSK) breakthrough therapy d...
Singapore: According to an international multiple sclerosis (MS) registry and a US health claims database, Novartis' Gi...
Singapore: Gilead Sciences has expanded its agreement with Ireland based Janssen for the development and commercializati...
Tokyo: Shionogi, one of Japan's century-old pharmaceutical manufacturers, has announced that its once-daily naldemedine ...
Singapore: Australian pharmaceutical company Pharmaxis, and UK biotechnology company, Synairgen, have entered into a res...
